Laird Norton Wetherby Wealth Management’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$285K Sell
6,388
-254
-4% -$12.2K 0.01% 768
2025
Q2
$319K Buy
+6,642
New +$289K 0.01% 699
2024
Q4
$338K Sell
7,379
-86
-1% -$3.85K 0.02% 662
2024
Q3
$350K Buy
7,465
+133
+2% +$6.07K 0.02% 676
2024
Q2
$310K Sell
7,332
-636
-8% -$27.9K 0.01% 700
2024
Q1
$352K Sell
7,968
-120
-1% -$5.47K 0.02% 686
2023
Q4
$372K Sell
8,088
-1,924
-19% -$81.8K 0.02% 647
2023
Q3
$430K Buy
10,012
+1,165
+13% +$54.3K 0.02% 570
2023
Q2
$422K Sell
8,847
-235
-3% -$11.3K 0.02% 601
2023
Q1
$442K Sell
9,082
-160
-2% -$8.14K 0.03% 579
2022
Q4
$489K Sell
9,242
-245
-3% -$12.1K 0.03% 527
2022
Q3
$415K Buy
9,487
+798
+9% +$39.4K 0.03% 554
2022
Q2
$435K Buy
8,689
+319
+4% +$15.6K 0.03% 551
2022
Q1
$435K Sell
8,370
-392
-4% -$20.2K 0.02% 568
2021
Q4
$516K Buy
8,762
+583
+7% +$33.4K 0.03% 514
2021
Q3
$448K Buy
8,179
+17
+0.2% +$947 0.03% 544
2021
Q2
$419K Sell
8,162
-485
-6% -$25K 0.03% 584
2021
Q1
$446K Sell
8,647
-384
-4% -$21.1K 0.03% 475
2020
Q4
$506K Buy
9,031
+322
+4% +$17.2K 0.03% 457
2020
Q3
$483K Sell
8,709
-98
-1% -$5.08K 0.04% 388
2020
Q2
$400K Buy
8,807
+237
+3% +$10.6K 0.04% 416
2020
Q1
$378K Buy
8,570
+364
+4% +$14.2K 0.04% 389
2019
Q4
$294K Sell
8,206
-744
-8% -$27.7K 0.03% 547
2019
Q3
$313K Sell
8,950
-357
-4% -$13.7K 0.03% 534
2019
Q2
$401K Buy
9,307
+106
+1% +$4.39K 0.04% 452
2019
Q1
$397K Sell
9,201
-50
-0.5% -$2.01K 0.05% 425
2018
Q4
$338K Buy
9,251
+455
+5% +$16.9K 0.05% 427
2018
Q3
$353K Sell
8,796
-56
-0.6% -$2.24K 0.04% 459
2018
Q2
$340K Buy
8,852
+153
+2% +$5.63K 0.05% 438
2018
Q1
$298K Buy
8,699
+90
+1% +$3.16K 0.04% 482
2017
Q4
$282K Sell
8,609
-38
-0.4% -$1.31K 0.04% 488
2017
Q3
$289K Sell
8,647
-83
-1% -$2.86K 0.04% 468
2017
Q2
$311K Sell
8,730
-15
-0.2% -$507 0.05% 421
2017
Q1
$269K Buy
+8,745
New +$270K 0.05% 455

Other funds holding QGEN

Laird Norton Wetherby Wealth Management's QGEN Position: Q3 2025 in Review

Laird Norton Wetherby Wealth Management reduced its Qiagen (QGEN) stake by 3.8% in Q3 2025, selling an estimated $12.2K and leaving 6,388 shares worth $285K. The position accounts for 0.01% of the portfolio, ranked #768.

Laird Norton Wetherby Wealth Management first reported a position in QGEN in Q1 2017 and has held it in 34 quarters since. The position peaked at $516K in Q4 2021. 338 funds tracked by Wall St. Rank hold QGEN as of Q3 2025.

  • Laird Norton Wetherby Wealth Management held 6,388 shares of Qiagen worth $285K as of Q3 2025.
  • Laird Norton Wetherby Wealth Management sold 254 Qiagen shares in Q3 2025, an estimated $12.2K.
  • Qiagen made up 0.01% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #768 holding.
  • Laird Norton Wetherby Wealth Management first reported a position in Qiagen in Q1 2017 and has held it in 34 quarters since.
  • Laird Norton Wetherby Wealth Management's Qiagen position peaked at $516K in Q4 2021.
  • 338 funds tracked by Wall St. Rank held Qiagen as of Q3 2025.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.